Vizora日本語

AFC-HD AMS Life ScienceAFC-HD AMS Life Science Co.,Ltd.2927東証スタンダード食料品FY ending Aug 2025, consolidated, J-GAAP

AFC-HD AMS Life Science FY ending Aug 2021 results

About 78% of AFC-HD AMS Life Science's sales come from Health care, with Department store business and Medical products making up much of the rest.

Out of every ¥100 of sales, about ¥10 is left as operating profit.

Revenue changed +41.4% from the prior year, operating profit +105.3%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +41.4% · profit +105.3%, calculated from disclosed figures.

Operating leverage: 2.54× (profit growth ÷ revenue growth)

What changed from last year

FY ending Aug 2020 → FY ending Aug 2021

Revenue
+41.4%¥15.8B → ¥22.4B
Gross profit
+50.7%¥4.55B → ¥6.87B
Operating income
+105.3%¥1.09B → ¥2.25B
Net income attributable to owners
+121.0%¥676.7M → ¥1.5B
Operating cash flow
+98.8%¥1.3B → ¥2.58B
Free cash flow
+127.8%¥917.7M → ¥2.09B

Where the money goes

FY ending Aug 2020 → FY ending Aug 2021

Where ¥100 of sales goes

For every ¥100 AFC-HD AMS Life Science sells, how much goes where, and how much is kept.

FY ending Aug 2021
Cost of sales
¥69
SG&A
¥21
Operating profit
¥10
Net profit kept
¥7

Annual margin trends

Gross margin30.7%
FY ending Aug 2019: 27.8%27.8%FY ending Aug 2020: 28.8%28.8%FY ending Aug 2021: 30.7%30.7%FY19FY20FY21
Operating margin10.0%
FY ending Aug 2019: 6.0%6.0%FY ending Aug 2020: 6.9%6.9%FY ending Aug 2021: 10.0%10.0%FY19FY20FY21
Net margin6.7%
FY ending Aug 2019: 4.8%4.8%FY ending Aug 2020: 4.3%4.3%FY ending Aug 2021: 6.7%6.7%FY19FY20FY21

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Aug 2021

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第45期(2024/09/01－2025/08/31)

    ID S100X6W82025-11-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第44期(2023/09/01－2024/08/31)

    ID S100UT2C2024-11-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第43期(2022/09/01－2023/08/31)

    ID S100SD2P2023-11-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第42期(令和3年9月1日－令和4年8月31日)

    ID S100PQ002022-11-30Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第41期(令和2年9月1日－令和3年8月31日)

    ID S100N0TK2021-12-08Open

  • EDINET (FSA Japan)

    有価証券報告書－第40期(令和1年9月1日－令和2年8月31日)

    ID S100K8NO2020-11-25Open

Extracted from XBRL: 56 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image